Programmed Cell Death in Human Ovary Is a Function of Follicle and Corpus Luteum Status*

作者: Wei Yuan , Linda C. Giudice

DOI: 10.1210/JCEM.82.9.4191

关键词: EndocrinologyProgrammed cell deathFollicular fluidDNA ladderingInternal medicineFolliculogenesisFollicular phaseOvarian follicleDNA fragmentationCorpus luteumBiologyClinical biochemistryBiochemistryEndocrinology, Diabetes and MetabolismBiochemistry, medical

摘要: Although extensive investigation on follicular apoptosis (programmed cell death) has been conducted in the infraprimate ovary, there is little information regarding apoptosis and its relationship to follicular status in the human. In this study, apoptosis was investigated in 116 human ovarian follicles (primordial to dominant) and 5 corpora lutea from a total of 27 premenopausal women. Follicles and corpora lutea were evaluated for the presence of DNA fragmentation, characteristic of apoptosis, by two methods: in situ hybridization using 3′ end-labeling of DNA with digoxigenin-labeled nucleotides and subsequent digoxigenin antibody and peroxidase staining, and/or biochemical analysis of low molecular weight DNA laddering. Follicle functional status was evaluated by determining follicle sizes and follicular fluid androgen/estrogen (A/E) ratios. No apoptosis was observed in 67 primordial, primary, or secondary follicles. Positive staining for DNA fragmentation was found in a few granulosa cells in 0.1- to 2-mm follicles, whereas abundant staining in granulosa was detected in 2.1- to 9.9-mm follicles. In contrast, no DNA fragmentation was detected in dominant follicles (10–16 mm). The frequency of apoptosis in follicles was calculated to be 37% in 0.1- to 2-mm follicles, 50% in 2.1- to 5-mm follicles, and 27% in 5.1- to 9.9-mm follicles. Abundant low molecular weight DNA laddering was only found in androgen-dominant follicles and not in estrogen-dominant follicles. Positive staining for DNA fragmentation and low molecular weight DNA laddering were observed in degenerating but not healthy-appearing corpora lutea. In the former, DNA fragmentation was found primarily in large luteal cells. These data suggest that follicular atresia in human ovary results from normal programmed cell death and primarily occurs in the granulosa cell layers of the early antral and <10-mm antral follicles primarily. Furthermore, because apoptosis occurs as early as the 200-mm stage, follicle selection may begin as early as the initial formation of the antrum. The results also suggest that degeneration of the corpus luteum occurs by apoptotic mechanisms.

参考文章(22)
Eli Y. Adashi, C. E. Resnick, R. G. Rosenfeld, D. R. Powell, R. Koistinen, E. M. Rutanen, M. Seppala, Insulin-Like Growth Factor (IGF) Binding Protein-1 is an Antigonadotropin: Evidence that Optimal Follicle-Stimulating Hormone Action in Ovarian Granulosa Cells is Contingent upon Amplification by Endogenously-Derived IGFs Advances in Experimental Medicine and Biology. ,vol. 343, pp. 377- 385 ,(1994) , 10.1007/978-1-4615-2988-0_35
T Shikone, M Yamoto, K Kokawa, K Yamashita, K Nishimori, R Nakano, Apoptosis of human corpora lutea during cyclic luteal regression and early pregnancy The Journal of Clinical Endocrinology and Metabolism. ,vol. 81, pp. 2376- 2380 ,(1996) , 10.1210/JCEM.81.6.8964880
H Billig, I Furuta, A J Hsueh, Estrogens inhibit and androgens enhance ovarian granulosa cell apoptosis. Endocrinology. ,vol. 133, pp. 2204- 2212 ,(1993) , 10.1210/ENDO.133.5.8404672
Jonathan L. Tilly, Kim I. Kowalski, Alan L. Johnson, Aaron J.W. Hsueh, Involvement of apoptosis in ovarian follicular atresia and postovulatory regression. Endocrinology. ,vol. 129, pp. 2799- 2801 ,(1991) , 10.1210/ENDO-129-5-2799
Y Funayama, H Sasano, T Suzuki, M Tamura, T Fukaya, A Yajima, Cell turnover in normal cycling human ovary. The Journal of Clinical Endocrinology and Metabolism. ,vol. 81, pp. 828- 834 ,(1996) , 10.1210/JCEM.81.2.8636311
H J Thierry van Dessel, Y Chandrasekher, O W Yap, P D Lee, R L Hintz, G H Faessen, D D Braat, B C Fauser, L C Giudice, Serum and follicular fluid levels of insulin-like growth factor I (IGF-I), IGF-II, and IGF-binding protein-1 and -3 during the normal menstrual cycle. The Journal of Clinical Endocrinology and Metabolism. ,vol. 81, pp. 1224- 1231 ,(1996) , 10.1210/JCEM.81.3.8772603
A el-Roeiy, X Chen, V J Roberts, S Shimasakai, N Ling, D LeRoith, C T Roberts, S S Yen, Expression of the genes encoding the insulin-like growth factors (IGF-I and II), the IGF and insulin receptors, and IGF-binding proteins-1-6 and the localization of their gene products in normal and polycystic ovary syndrome ovaries. The Journal of Clinical Endocrinology and Metabolism. ,vol. 78, pp. 1488- 1496 ,(1994) , 10.1210/JCEM.78.6.7515389
HD Mason, D Willis, JMP Holly, SC Cwyfan-Hughes, M Seppala, S Franks, None, Inhibitory effects of insulin-like growth factor-binding proteins on steroidogenesis by human granulosa cells in culture. Molecular and Cellular Endocrinology. ,vol. 89, ,(1992) , 10.1016/0303-7207(92)90224-T
N A Cataldo, L C Giudice, Follicular fluid insulin-like growth factor binding protein profiles in polycystic ovary syndrome The Journal of Clinical Endocrinology and Metabolism. ,vol. 74, pp. 695- 697 ,(1992) , 10.1210/JCEM.74.3.1371292